The Buffalo Institute for Genomics & Data Analytics (BIG) partners with institutions and facilities across New York State in leading genomics research and technology.
New York Genome Center
The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. NYGC’s Integrated Genomics include experimental design assistance, sample quality control processes, library preparation, sequencing, extensive data quality control, bioinformatics and data storage.
NYSERNet is a private not-for-profit corporation created to foster science and education in New York State. Its mission is to advance network technology and related applications to satisfy needs common to the institutions comprising New York State's research and education community, providing a forum for exploration of the opportunities and challenges these innovations present. An Internet pioneer, NYSERNet has delivered next-generation Internet services to New York State's research and education community for 30 years.
BIG partners with companies, providing them access to expertise, research capabilities and supercomputing resources. This boosts the creation of new approaches to personalized medicine, diagnostics and technologies created in Western New York.
Circuit Clinical personalizes medicine by bringing studies to the physicians that patients know and trust. The company streamlines the process while removing cost for physicians in order to bring new medical solutions to patients.
As part of its engagement with BIG, Circuit Clinical will expand its technology platform and bring software development jobs to Buffalo.
Created in 2006 by University at Buffalo faculty member Dr. Norma Jean Nowak, a recognized leader in the field of genomics, from research started at Roswell Park Cancer Institute. The laboratory has a strong track record in the development of high throughput technologies to enable genome-wide analyses aimed at determining the underlying mechanisms for diseases. Having played a fundamental role in the Human Genome Project and created the foundational Bacterial Artificial Chromosomes, which served as the basis for sequencing the genome, Empire Genomics developed significant expertise in genomic research.
Garwood Medical is an advanced medical device company whose products will positively enhance clinical outcomes related to infection. Through advanced technology and novel designs, Garwood Medical is committed to disrupt the wound care and perio-prosthetic market by advancing infection control through innovation.
A strategic partnership with BIG provides the company with a state of the art research and development site and a robust university engineering team. This public-private partnership will drive Garwood’s and UB’s technologies through development, by performing all aspects of research, device modeling, rational product design and prototyping, focusing on verifications, validations and characterizations of the applications and imbedded technologies.